Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial (Q38410120)
Jump to navigation
Jump to search
scientific article published on 09 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial |
scientific article published on 09 June 2015 |
Statements
1 reference
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial (English)
1 reference
Kenneth W Mahaffey
1 reference
Sharon M Moe
1 reference
Patrick S Parfrey
1 reference
Yumi Kubo
1 reference
Geoffrey A Block
1 reference
Ricardo Correa-Rotter
1 reference
Tilman B Drüeke
1 reference
Charles A Herzog
1 reference
Gerard M London
1 reference
David C Wheeler
1 reference
Maria Stolina
1 reference
Bastian Dehmel
1 reference
William G Goodman
1 reference
Jürgen Floege
1 reference
Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*
1 reference
9 June 2015
1 reference
1 reference
132
1 reference
1
1 reference
27-39
1 reference
Identifiers
1 reference
1 reference